When one in five US legislators hold financial interests in AI companies, regulation becomes performative theatre. UK regulated firms cannot afford to wait for clarity that may never come from authorities facing identical conflicts.
AI Governance  Trovix AriaLegal · Insurance · Financial Services · Accountancy

The Washington Post's October report reveals that roughly 20% of Congress holds household investments in AI infrastructure or model development companies—yet Congress has still failed to pass meaningful AI regulation despite mounting warnings about systemic risks. This matters enormously for UK legal, insurance, financial services and accountancy firms because it exposes a uncomfortable truth: regulatory capture is already happening in the world's largest economy, and UK regulators are not immune to the same pressures. When the FCA, SRA, PRA and ICO are shaped by policymakers and advisers with financial stakes in the AI vendors they are supposed to oversee, the regulatory frameworks that supposedly protect UK firms become aspirational rather than enforceable. The FCA's Consumer Duty PS22/9 and the SRA's Code assume regulators will act in the public interest. They may be wrong.

This is not a problem unique to Congress. It is the defining problem of AI regulation globally. The EU's AI Act arrived only after years of delay. The UK's principles-based approach to AI governance—deliberately light-touch—was partly shaped by voices whose commercial interests lay in fast deployment over rigorous oversight. What the Congressional story reveals is not an anomaly but a pattern: regulators and legislators worldwide are betting on AI's growth precisely because they or their circles profit from it. This creates a perverse incentive: the riskier the AI system, the greater the upside for those positioned to benefit. Mid-market firms are left to navigate this vacuum by themselves.

Trovix's answer to this regulatory ambiguity is deliberate. We do not position AI as a replacement for human judgment in high-stakes decisions—unlike Harvey, Luminance or Legora, which market themselves as autonomous legal analysis engines capable of reasoning and risk assessment. Those products are built on a fundamental assumption: that you can offshore your compliance responsibility to the algorithm. We reject this. Instead, Trovix Audit makes human oversight and auditability non-negotiable. Every decision the system influences is traceable, explainable and reviewable by your team. This is not a marketing constraint; it is a survival strategy. When regulators eventually tighten—and they will—firms using opaque, autonomous AI will face enforcement action. Firms with documented human-in-the-loop governance will not. Similarly, Trovix Aria and Trovix Reach are designed as amplifiers for your team's expertise, not replacements for it. They reduce grunt work; they do not reduce your accountability.

If you are a mid-market law firm, insurer or financial services practice, the immediate action is not to wait for regulation. It is to assume regulation will be strict when it arrives and to implement AI governance now that assumes maximum scrutiny. Document how AI is being used in your practice. Establish which decisions humans must make and which can be assisted. If a vendor cannot explain how their system works or cannot audit its outputs, do not deploy it—no matter how much efficiency it promises. The FRC ISA UK, PRA SS1/23 and upcoming ICO guidance on AI will require this anyway. The firms that move now will be compliant by default. The firms that deployed Luminance or Copilot without governance will be scrambling.

Source: Washington Post

Related Trovix product:

Trovix Aria →Book a demo →